XML 38 R28.htm IDEA: XBRL DOCUMENT v3.24.3

Acquisition and Disposition (Tables)

9 Months Ended

Sep. 30, 2024

Acquisition And Disposal Of Business [Abstract]

Schedule of purchase price allocation to the estimated fair value of the net assets acquired

​

​	​	​	​
(in thousands)	​	Amounts Recognized at Acquisition Date
Assets Acquired	​	​	​
Cash and cash equivalents	​	$	6,997
Investments in marketable securities	​	​	21,791
Prepaids and other assets	​	​	5,260
In-process research and development	​	​	26,239
Out-licenses	​	​	13,530
Total assets	​	$	73,817
Liabilities Assumed	​	​	​
Accrued and other current liabilities	​	$	7,722
Deferred tax liability	​	​	1,499
Total liabilities	​	​	9,221
Total net assets acquired	​	$	64,596

Schedule of amounts allocated to identifiable intangible assets

​

​	​	​	​	​	​
(in thousands)	​	Useful lives		​	Fair Value at Acquisition Date
In-process research and development - casdozokitug	​	n/a	​	$	25,899
In-process research and development - CHS-114	​	n/a	​	​	340
Out-license - GSK	​	15 years	​	​	2,506
Out-license - Novartis Institutes	​	15 years	​	​	11,024
Total identifiable intangible assets	​	​	​	$	39,769

Schedule of unaudited pro forma summary of operations

​

​	​	​	​	​	​	​
​	​	Three Months Ended		​	Nine Months Ended
(in thousands)	​	September 30, 2023		​	September 30, 2023
Total revenues	​	$	74,568	​	$	165,720
Net loss	​	$	(49,984)	​	$	(204,922)

X

- References

No definition available.

+ Details

Name:	chrs_AcquisitionAndDisposalOfBusinessAbstract
Namespace Prefix:	chrs_
Data Type:	xbrli:stringItemType
Balance Type:	na
Period Type:	duration

X

- Definition

Tabular disclosure of pro forma results of operations for a material business acquisition or series of individually immaterial business acquisitions that are material in the aggregate.

+ References

Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
-Name Accounting Standards Codification
-Section 50
-Paragraph 2
-Subparagraph (h)(2)
-SubTopic 10
-Topic 805
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147479328/805-10-50-2

Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef
-Name Accounting Standards Codification
-Section 50
-Paragraph 2
-Subparagraph (h)(3)
-SubTopic 10
-Topic 805
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147479328/805-10-50-2

+ Details

Name:	us-gaap_BusinessAcquisitionProFormaInformationTextBlock
Namespace Prefix:	us-gaap_
Data Type:	dtr-types:textBlockItemType
Balance Type:	na
Period Type:	duration

X

- Definition

Tabular disclosure of finite-lived and indefinite-lived intangible assets acquired as part of a business combination.

+ References

No definition available.

+ Details

Name:	us-gaap_FiniteLivedAndIndefiniteLivedIntangibleAssetsAcquiredAsPartOfBusinessCombinationTableTextBlock
Namespace Prefix:	us-gaap_
Data Type:	dtr-types:textBlockItemType
Balance Type:	na
Period Type:	duration

X

- Definition

Tabular disclosure of the amounts recognized as of the acquisition date for each major class of assets acquired and liabilities assumed. May include but not limited to the following: (a) acquired receivables; (b) contingencies recognized at the acquisition date; and (c) the fair value of noncontrolling interests in the acquiree.

+ References

Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Topic 805
-SubTopic 20
-Name Accounting Standards Codification
-Paragraph 1
-Section 50
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147479907/805-20-50-1

+ Details

Name:	us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock
Namespace Prefix:	us-gaap_
Data Type:	dtr-types:textBlockItemType
Balance Type:	na
Period Type:	duration